Medasense launch PMD200[TM] nach CE-Kennzeichung in Europa, neues Produkt zur Schmerzmessung - Seite 3

Weitere Medienressourcen  

Hintergrund zum Produkt - http://www.medasense.com/wp-content/uploads/2017/01/Medasense-Backgrounder-PMD-200-Product-1.2017.pdf

Hintergrund zu Schmerzen bei der Operation - http://www.medasense.com/wp-content/uploads/2017/01/Medasense-Pain-during-surgery-and-objective-measurement-1.2017.pdf

PMD200™ Video - http://www.medasense.com/about-us/media-resource-center/

Literatur:  

1. Cowen R et al., (2015) Assessing pain objectively: the use of physiological markers. Anaesthesia, 70:828-847
2. Gan TJ et al., (2014) Incidence, patient satisfaction, and perceptions pf post-surgical pain: Results from a US national survey. Current Medical Research and Opinion. 30:149-60
3. Pogatzki-Zahn E et al., (2015) A Prospective Multicenter Study to Improve Postoperative Pain: Identification of Potentialities and Problems. Plos One, 10:e0143508
4. Benyamin R et al., (2008) Opioid Complications and Side Effects. Pain Physician: Opioid Special Issue. 11:S105-S120
5. Joly V et al., (2005) Remifentanil-induced postoperative hyperalgesia and its prevention with small dose ketamine. Anesthesiology, 103:147-55
6. Julien M et al., (2016) Nociception Level (NoL) index alteration after standardized nociceptive stimulus decreases with higher doses of remifentanil. Abstract:European Society of Anaesthesiology.
7. Edry R et al., (2016) Intraoperative validation of the NOL Index, a non-invasive nociception monitor. Anesthesiology, 125:193-203

Ansprechpartner für Medien

Kate Perry
Telefon: [phone]
E-Mail: [e-mail]